ArticleClinical & experimental metastasis2002

Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.

Hideo Maki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.